Metabolic reprogramming in the tumor microenvironment of liver cancer

被引:10
|
作者
Lin, Jian [1 ,4 ]
Rao, Dongning [2 ]
Zhang, Mao [2 ]
Gao, Qiang [1 ,2 ,3 ]
机构
[1] Fudan Univ, Jinshan Hosp, Ctr Tumor Diag & Therapy, Shanghai, Peoples R China
[2] Fudan Univ, Zhongshan Hosp, Liver Canc Inst, Dept Liver Surg & Transplantat,Key Lab Carcinogene, Shanghai 200032, Peoples R China
[3] Fudan Univ, Inst Biomed Sci, Key Lab Med Epigenet & Metab, Shanghai 200032, Peoples R China
[4] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Zhejiang Prov Key Lab Pancreat Dis, Hangzhou, Peoples R China
基金
中国国家自然科学基金;
关键词
Liver cancer; Metabolic reprogramming; Immune microenvironment; Gut-liver axis; T-CELL METABOLISM; HEPATOCELLULAR-CARCINOMA; LACTIC-ACID; PROTEOGENOMIC CHARACTERIZATION; GLUCOSE TRANSPORTERS; ENHANCES SURVIVAL; SUPPRESSOR-CELLS; GUT MICROBIOME; DOUBLE-BLIND; PHASE-I;
D O I
10.1186/s13045-024-01527-8
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The liver is essential for metabolic homeostasis. The onset of liver cancer is often accompanied by dysregulated liver function, leading to metabolic rearrangements. Overwhelming evidence has illustrated that dysregulated cellular metabolism can, in turn, promote anabolic growth and tumor propagation in a hostile microenvironment. In addition to supporting continuous tumor growth and survival, disrupted metabolic process also creates obstacles for the anticancer immune response and restrains durable clinical remission following immunotherapy. In this review, we elucidate the metabolic communication between liver cancer cells and their surrounding immune cells and discuss how metabolic reprogramming of liver cancer impacts the immune microenvironment and the efficacy of anticancer immunotherapy. We also describe the crucial role of the gut-liver axis in remodeling the metabolic crosstalk of immune surveillance and escape, highlighting novel therapeutic opportunities.
引用
收藏
页数:19
相关论文
共 50 条
  • [31] The roles of epigallocatechin gallate in the tumor microenvironment, metabolic reprogramming, and immunotherapy
    Li, Dongming
    Cao, Donghui
    Sun, Yuanlin
    Cui, Yingnan
    Zhang, Yangyu
    Jiang, Jing
    Cao, Xueyuan
    [J]. FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [32] Lipid metabolic reprogramming in tumor microenvironment: from mechanisms to therapeutics
    Jin, Hao-Ran
    Wang, Jin
    Wang, Zi-Jing
    Xi, Ming-Jia
    Xia, Bi-Han
    Deng, Kai
    Yang, Jin-Lin
    [J]. JOURNAL OF HEMATOLOGY & ONCOLOGY, 2023, 16 (01)
  • [33] Lipid metabolic reprogramming in tumor microenvironment: from mechanisms to therapeutics
    Hao-Ran Jin
    Jin Wang
    Zi-Jing Wang
    Ming-Jia Xi
    Bi-Han Xia
    Kai Deng
    Jin-Lin Yang
    [J]. Journal of Hematology & Oncology, 16
  • [34] Effect of metabolic reprogramming on the immune microenvironment in gastric cancer
    Shang, Zhengye
    Ma, Zhiyuan
    Wu, Enqin
    Chen, Xingzhao
    Tuo, Biguang
    Li, Taolang
    Liu, Xuemei
    [J]. BIOMEDICINE & PHARMACOTHERAPY, 2024, 170
  • [35] Metabolic Reprogramming of Thyroid Cancer Cells and Crosstalk in Their Microenvironment
    Bao, Lisha
    Xu, Tong
    Lu, Xixuan
    Huang, Ping
    Pan, Zongfu
    Ge, Minghua
    [J]. FRONTIERS IN ONCOLOGY, 2021, 11
  • [36] TLR-mediated metabolic reprogramming in the tumor microenvironment: potential novel strategies for cancer immunotherapy
    Huang, Lan
    Xu, Huaxi
    Peng, Guangyong
    [J]. CELLULAR & MOLECULAR IMMUNOLOGY, 2018, 15 (05) : 428 - 437
  • [37] Extracellular vesicles in cancer: Shaping the intricate network of metabolic reprogramming and immune interactions in the tumor microenvironment
    Giovannetti, Elisa
    Li, Tian
    [J]. CYTOKINE & GROWTH FACTOR REVIEWS, 2023, 73 : 1 - 2
  • [38] VDAC1 Silencing in Cancer Cells Leads to Metabolic Reprogramming That Modulates Tumor Microenvironment
    Zerbib, Erez
    Arif, Tasleem
    Shteinfer-Kuzmine, Anna
    Chalifa-Caspi, Vered
    Shoshan-Barmatz, Varda
    [J]. CANCERS, 2021, 13 (11)
  • [39] TLR-mediated metabolic reprogramming in the tumor microenvironment: potential novel strategies for cancer immunotherapy
    Lan Huang
    Huaxi Xu
    Guangyong Peng
    [J]. Cellular & Molecular Immunology, 2018, 15 : 428 - 437
  • [40] Reprogramming the tumor microenvironment to improve the efficacy of cancer immunotherapies
    Jabar A. Faraj
    Ali Jihad Hemid Al-Athari
    Sharaf El Din Mohie
    Iman Kareem Kadhim
    Noor Muhsen Jawad
    Weaam J. Abbas
    Abduladheem Turki Jalil
    [J]. Medical Oncology, 39